Mizuho Increases Lam Research (NASDAQ:LRCX) Price Target to $100.00

Lam Research (NASDAQ:LRCXGet Free Report) had its price target hoisted by research analysts at Mizuho from $87.00 to $100.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the semiconductor company’s stock. Mizuho’s target price indicates a potential upside of 11.80% from the stock’s previous close.

LRCX has been the topic of several other reports. KeyCorp raised shares of Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price target on the stock in a research report on Friday, January 17th. Stifel Nicolaus reaffirmed a “buy” rating and set a $100.00 price target (down from $105.00) on shares of Lam Research in a research report on Thursday, October 24th. Barclays lowered their price target on shares of Lam Research from $90.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company raised their price target on shares of Lam Research from $82.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 30th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $90.00 price target on shares of Lam Research in a research report on Thursday, January 30th. Six research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and an average price target of $98.22.

View Our Latest Stock Analysis on Lam Research

Lam Research Stock Up 2.0 %

Shares of LRCX stock traded up $1.78 during trading on Thursday, reaching $89.44. The company’s stock had a trading volume of 6,349,197 shares, compared to its average volume of 12,102,325. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51. The business has a fifty day moving average price of $78.00 and a 200-day moving average price of $77.90. Lam Research has a one year low of $68.87 and a one year high of $113.00. The company has a market cap of $114.81 billion, a price-to-earnings ratio of 27.17, a price-to-earnings-growth ratio of 1.43 and a beta of 1.46.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. Analysts anticipate that Lam Research will post 3.71 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Lam Research by 2,400.0% in the 3rd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 200 shares of the semiconductor company’s stock valued at $163,000 after acquiring an additional 192 shares in the last quarter. Insight Wealth Partners LLC bought a new stake in shares of Lam Research in the 3rd quarter valued at $202,000. B&L Asset Management LLC bought a new stake in shares of Lam Research in the 3rd quarter valued at $204,000. CWC Advisors LLC. bought a new stake in shares of Lam Research in the 3rd quarter valued at $220,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Lam Research in the 3rd quarter valued at $220,000. Institutional investors own 84.61% of the company’s stock.

About Lam Research

(Get Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.